Fischer Medical Ventures Limited (FISCHER) reported revenue of ₹81.92 Cr and net profit of ₹3.79 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
FISCHER fundamentals, Fundamental score 65/100
The statements below are read from Fischer Medical Ventures Limited’s filed results, 12 filed quarters and 4 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 15, 2026 · audited
Sales CAGR · 3Y—FY22 → FY25
Sales CAGR · 4Y——
PAT CAGR · 3Y—FY22 → FY25
PAT CAGR · 4Y——
Price · 1Y−66.9%EOD
Price CAGR · 3Y—EOD
Consolidated view — the full group. Fischer Medical Ventures Limited's standalone figures are parent-only (₹1 cr), a fraction of the group.
Quarterly resultsConsolidated
₹ Cr
Jun2023
Sep2023
Mar2024
Jun2024
Sep2024
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
0.00
0.00
20.8
10.1
39.7
11.7
49.2
23.4
86.3
101
97.7
81.9
+249.4%
0.00
0.00
18.3
10.3
39.2
11.2
46.7
19.2
70.1
79.5
96.7
70.7
+268.4%
Operating profit
—
0.00
2.52
-0.17
0.50
0.50
2.50
4.26
16.3
21.6
1.00
11.3
+164.1%
OPM %
—
—
12.1%
-1.7%
1.3%
4.3%
5.1%
18.2%
18.8%
21.3%
1.0%
13.7%
-4.4 pp
Other income
0.00
0.00
0.47
0.74
0.05
0.38
0.15
7.47
2.48
1.09
1.28
1.48
-80.1%
Interest
—
0.00
0.05
0.13
0.05
0.07
0.23
0.67
0.92
0.64
3.61
3.54
n/m
Depreciation
—
0.00
0.18
0.28
0.29
0.56
0.51
0.77
0.51
0.77
0.93
1.36
+76.7%
Profit before tax
0.00
0.00
2.75
—
—
—
1.81
10.3
17.3
21.2
-2.25
7.83
-23.9%
Tax %
n/a (loss)
n/a (loss)
6.1%
—
—
—
27.6%
50.2%
19.5%
9.2%
n/a (loss)
51.6%
+1.4 pp
Net profit
0.00
0.00
2.59
-0.12
0.29
-0.29
1.31
5.01
13.9
19.2
-7.12
3.79
-24.3%
EPS (₹)
—
0.00
—
—
—
—
0.01
0.08
2.15
0.30
-0.11
0.06
-22.1%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split · n/a (loss) = tax rate undefined on a loss↔ scroll for earlier quarters
Revenue & net profit trend
last 12 quarters
RevenueNet profit
Revenue & net profit — Consolidated12 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±4.2%· EPS surprise: no estimates source· 7 earlier quarters have no dated filing on record
Q1'27filed Fri 14 Aug 20:31 · first tradeable session Mon 17 Auggap −4.2%close −3.5%
Q4'26filed Sun 31 May 22:32 · first tradeable session Mon 1 Jungap −5.0%close −5.0%
Q3'26filed Fri 30 Jan 18:29 · first tradeable session Sun 1 Febgap +3.1%close −2.5%
Q2'26filed Tue 28 Oct 21:29 · first tradeable session Wed 29 Octgap +8.2%close +5.7%
Q1'26filed Thu 14 Aug 13:50 · traded that sessiongap +1.2%close +3.9%
